|
1
|
Driessen HP, de Jong WW, Tesser GI and
Bloemendal H: The mechanism of N-terminal acetylation of proteins.
CRC Crit Rev Biochem. 18:281–325. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jeong JW, Bae MK, Ahn MY, et al:
Regulation and destabilization of HIF-1alpha by ARD1-mediated
acetylation. Cell. 111:709–720. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lim JH, Park JW and Chun YS: Human arrest
defective 1 acetylates and activates beta-catenin, promoting lung
cancer cell proliferation. Cancer Res. 66:10677–10682. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohkawa N, Sugisaki S, Tokunaga E, et al:
N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic
development. Genes Cells. 13:1171–1183. 2008.PubMed/NCBI
|
|
5
|
Shin DH, Chun YS, Lee KH, Shin HW and Park
JW: Arrest defective-1 controls tumor cell behavior by acetylating
myosin light chain kinase. PLoS One. 4:e74512009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim SH, Park JA, Kim JH, et al:
Characterization of ARD1 variants in mammalian cells. Biochem
Biophys Res Commun. 340:422–427. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chun KH, Cho SJ, Choi JS, Kim SH, Kim KW
and Lee SK: Differential regulation of splicing, localization and
stability of mammalian ARD1235 and ARD1225 isoforms. Biochem
Biophys Res Commun. 353:18–25. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arnesen T, Kong X, Evjenth R, et al:
Interaction between HIF-1 alpha (ODD) and hARD1 does not induce
acetylation and destabilization of HIF-1 alpha. FEBS Lett.
579:6428–6432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fisher TS, Etages SD, Hayes L, Crimin K
and Li B: Analysis of ARD1 function in hypoxia response using
retroviral RNA interference. J Biol Chem. 280:17749–17757. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bilton R, Mazure N, Trottier E, et al:
Arrest-defective-1 protein, an acetyltransferase, does not alter
stability of hypoxia-inducible factor (HIF)-1alpha and is not
induced by hypoxia or HIF. J Biol Chem. 280:31132–31140. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seo JH, Cha JH, Park JH, et al: Arrest
defective 1 autoacetylation is a critical step in its ability to
stimulate cancer cell proliferation. Cancer Res. 70:4422–4432.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arnesen T, Gromyko D, Pendino F, Ryningen
A, Varhaug JE and Lillehaug JR: Induction of apoptosis in human
cells by RNAi-mediated knockdown of hARD1 and NATH, components of
the protein N-alpha-acetyltransferase complex. Oncogene.
25:4350–4360. 2006. View Article : Google Scholar
|
|
13
|
Ren T, Jiang B, Jin G, et al: Generation
of novel monoclonal antibodies and their application for detecting
ARD1 expression in colorectal cancer. Cancer Lett. 264:83–92. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shim JH, Chung YH, Kim JA, et al: Clinical
implications of arrest-defective protein 1 expression in
hepatocellular carcinoma: a novel predictor of microvascular
invasion. Dig Dis. 30:603–608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang ZH, Gong JL, Yu M, et al:
Up-regulation of human arrest-defective 1 protein is correlated
with metastatic phenotype and poor prognosis in breast cancer.
Asian Pac J Cancer Prev. 12:1973–1977. 2011.PubMed/NCBI
|
|
16
|
Yu M, Gong J, Ma M, et al:
Immunohistochemical analysis of human arrest-defective-1 expressed
in cancers in vivo. Oncol Rep. 21:909–915. 2009.PubMed/NCBI
|
|
17
|
Thompson PR, Wang D, Wang L, et al:
Regulation of the p300 HAT domain via a novel activation loop. Nat
Struct Mol Biol. 11:308–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Santos-Rosa H, Valls E, Kouzarides T and
Martinez-Balbas M: Mechanisms of P/CAF auto-acetylation. Nucleic
Acids Res. 31:4285–4292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blanco-Garcia N, Asensio-Juan E, de la
Cruz X and Martinez-Balbas MA: Autoacetylation regulates P/CAF
nuclear localization. J Biol Chem. 284:1343–1352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stavropoulos P, Nagy V, Blobel G and Hoelz
A: Molecular basis for the autoregulation of the protein acetyl
transferase Rtt109. Proc Natl Acad Sci USA. 105:12236–12241. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee MN, Lee SN, Kim SH, et al: Roles of
arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha
in tumor growth and metastasis. J Natl Cancer Inst. 102:426–442.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murray-Rust TA, Oldham NJ, Hewitson KS and
Schofield CJ: Purified recombinant hARD1 does not catalyse
acetylation of Lys532 of HIF-1alpha fragments in vitro. FEBS Lett.
580:1911–1918. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
24
|
Hong SS, Lee H and Kim KW: HIF-1alpha: a
valid therapeutic target for tumor therapy. Cancer Res Treat.
36:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1)alpha: its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arnesen T, Thompson PR, Varhaug JE and
Lillehaug JR: The protein acetyltransferase ARD1: a novel cancer
drug target? Curr Cancer Drug Targets. 8:545–553. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nilsen TW and Graveley BR: Expansion of
the eukaryotic proteome by alternative splicing. Nature.
463:457–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brett D, Pospisil H, Valcarcel J, Reich J
and Bork P: Alternative splicing and genome complexity. Nat Genet.
30:29–30. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mironov AA, Fickett JW and Gelfand MS:
Frequent alternative splicing of human genes. Genome Res.
9:1288–1293. 1999. View Article : Google Scholar : PubMed/NCBI
|
